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EEG Findings in Infants With
Neonatal Abstinence Syndrome
Presenting With Clinical Seizures
Murali Reddy Palla*, Gulam Khan, Zahra M. Haghighat and Henrietta Bada
Division of Neonatology, Department of Pediatrics, University of Kentucky, Lexington, KY, United States
Neonatal abstinence syndrome (NAS) refers to a constellation of signs occurring
in newborn infants who were exposed to opioids or opiates in utero. These
manifestations include poor feeding, gastrointestinal disorders, abnormal sleep patterns,
and neurological signs such as jitteriness, tremors, and seizures (1, 2). Myoclonus,
jitteriness, and tremors often may be interpreted as seizures and therefore treated as
epileptic seizures.
Objective: To determine whether seizure like activity observed in infants with NAS
correlate with electroencephalogram (EEG) findings.
Design/ Method: We reviewed the standard EEG or video electroencephalogram
(VEEG) of infants with NASwhowere admitted because of seizure-like clinical activity. The
exclusion criteria were major neurological anomalies, hypoxic ischemic encephalopathy,
metabolic disorders, or with clinical diagnosis other than NAS.
Results: Forty neonates met study criteria; 28 had standard EEG recordings and 18
had VEEG. Mean gestational age was 38.5 weeks. The onset of seizure-like clinical
activity was as early as day 1 and as late as day 16 of life. The clinical seizure-like activity
described at the referring hospital were jerking, rhythmic movement of the extremities,
or tremors. Only three (7.5%) neonates had epileptic seizures. There were increased
sharp transients in frontal, central, temporal, and or occipital regions. VEEG showed
disturbed non-rapid eye movement (REM) sleep with frequent arousal, jittery movements,
or sleep myoclonus.
Conclusion: Clinical seizure-like activity correlates poorly with epileptic seizures in
infants with NAS. In neonates with NAS, a VEEG would be useful to determine
if the clinical seizure-like activity is of epileptic origin or not, prior to initiation of
anti-seizure medications.
Keywords: seizures, neonatal abstinence syndrome, electroencephalography, prenatal opiate exposure,
sleep myoclonus
INTRODUCTION
Neonatal abstinence syndrome (NAS) is a clinical diagnosis, and a consequence of the abrupt
discontinuation of chronic fetal exposure to substances, specifically opiates or opioids used by
the mother during pregnancy. The prolonged half-life of opioids in the infants and the ease with
which opioids can cross the fetal blood-brain barrier of the fetus may increase the severity of
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withdrawal manifestations in infants with NAS (3). Furthermore,
accumulation of the drug in the fetus may result in the increased
production of various neurotransmitters through a cascade of
enzymatic activities (4). Locus coeruleus is the most important
center of activity in opioid withdrawal. This is the principal
noradrenergic nucleus of the brain and is extremely sensitive
to opioid status (5), i.e., withdrawal of the inhibitory effect of
opiate on the adrenergic neurons results in the hyperactivity
of these neurons (6). Most infant with NAS manifests with
central nervous system irritability, autonomic over reactivity,
and gastrointestinal tract dysfunction. Central nervous system
manifestations reported withNAS are tremors, exaggeratedMoro
reflex, hypertonia, and myoclonic jerks (7). These can mimic
seizures and therefore, an EEG may be required for confirmation
prior to treatment.
Of neonates with NAS, 2–11% manifest with seizures (8). The
underlying cause of seizures in NAS is not known, although
the threshold for seizure activity may be decreased due to
upregulation of sodium channels as a result of receptor instability
(9). NAS may involve a short intense initial phase, consisting
of tremors, seizures, irritability, feeding problems, vomiting,
diarrhea, hyperthermia, and other systemic signs which lasts
for upto 1–2 weeks. Later initial phase may be followed by a
long chronic and relapsing course that includes hyperirritability,
sleep disturbances, hyperphagia, and other neurologic and
autonomic signs (lasting for a few weeks to a few months)
(10). NAS symptoms depend on the type of drug exposure.
In intrauterine opioids exposure, such as heroin is associated
with earlier onset and shorter duration of withdrawal, compared
to methadone or buprenorphine, which is associated with late
onset and prolonged withdrawal. In the nonopioids class, meth-
amphetamine exposure is associated with early withdrawal
symptoms (11).
The jerking movement in NAS may be interpreted as
seizures, thus an indication for anti-convulsant therapy.
However, these jerking movements may represent benign
neonatal sleep myoclonus (BNSM), which has been
reported in neonates with NAS (1). Benign neonatal sleep
myoclonus (BNSM) is a phenomenon typically observed in
newborns during the first 4 weeks of life. This condition
is not associated with abnormal EEG. BNSM does not
need treatment and does not affect neurodevelopmental
outcome (12–14).
Since clinical observation of myoclonus, jitteriness, or tremors
can be misinterpreted as epileptic seizures, it prompted us
to explore the association between myoclonus, jitteriness,
tremors, and or seizure-like activity and EEG findings in
babies with NAS.
METHODS
This retrospective study had approval by the Institutional
Review Board (IRB) and met compliance with the Health
Insurance Portability and Accountability Act. The IRB waived
informed consent procedure for this study. Inclusion criteria
included admission to the neonatal intensive care unit, history of
intrauterine opioid exposure with or without other substances,
seizure-like activity reported as a clinical manifestation, and
the infant having had routine EEG or VEEG. Opioid exposure
refers to a mother admitting use during pregnancy or had
a positive urine test for opioids or the baby had positive
urine or meconium drug test. Seizure-like manifestation was
described as jerking or rhythmic movement of extremities,
myoclonus during sleep, apnea, and/or tremors. The exclusion
criteria were major neurological anomalies, hypoxic ischemic
encephalopathy, metabolic disorders, or with clinical diagnosis
other than NAS. Interval assessment or monitoring of these
infants used the Finnegan Neonatal Abstinence Scoring System
(2). Oxygen saturation monitored by pulse oximetry, blood
glucose; sodium, potassium, and calcium were monitored. All
infants were monitored with Finnegan scoring system. If 3
consecutive scores were ≥8 or 2 consecutive scores of ≥12,
infants were treated with morphine escalated and weaned
according to the unit protocol. If infants had electrographic
seizures, they were treated as per our neonatal intensive care unit
(NICU) guidelines.
The EEG and VEEG were reviewed by one of the investigators
(GK), a pediatric epileptologist. Routine EEG was done for 1 h
and VEEG was done for 48 h. The Xltek EEG/PSG System (Natus
Neuro Inc., Pleasanton, CA) was used for both EEG and VEEG; it
has components needed for EEG and VEEG. The EEG and VEEG
waveforms were assessed for the background activity, sharp
transients, and electrographic seizures. Background activity
is considered normal if there is no focal slowing and no
prolonged “trace alternant” (in term neonates 6–8 s is normal).
Sharp transients are normally present in newborn infants but
disappear by 50 weeks of post conceptional age. Sharp transients
that are repetitive in same area with slow background and
increased frequency are considered abnormal (15). Neonatal
electrographic seizure refers to a sudden, repetitive, evolving,
and stereotyped event of abnormal electrographic pattern with
amplitude of at least 2 µV and a minimum duration of 10 s
(16). Descriptive statistics were used and no EEG scoring system
was used.
RESULTS
Forty neonates with NAS were admitted to our level IV neonatal
intensive care unit (NICU) for seizure-like manifestation during
January 2010- November 2015. The patient characteristics are
shown in Table 1. There were 23 males and 17 females. The
mean (SD) gestational age was 37.5 (1.9) weeks and mean
(SD) birth weight was 2,843 (620) grams. All infants were
exposed to tobacco during pregnancy and of whom 29 infants
were exposed to opioids only. The remaining 11 infants were
exposed to more than one drug (marijuana, benzodiazepines,
methamphetamines, and/or gabapentin).The onset of seizure-
like manifestation was as early as day 1 and as late as day
16 of life, mean (SD) of 4.1 (4) days. Twenty-seven neonates
were treated for seizure-like clinical sign at the referring hospital
before EEG was performed; 23 were treated with phenobarbital,
two with morphine, and one with levetiracetam. In these
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TABLE 1 | Patient characteristics.
Total number of subjects 40
Males 23 (57.5%)
Females 17 (42.5%)
Mean gestational age (SD) 37.5 weeks (1.9)
Mean birth weight (SD) 2,843 g (620)
Intrauterine exposure to single drug 29 (72.5%)
Intrauterine exposure to poly drugs 11 (27.5%)
Day of life onset of reported seizure,
mean (SD)
4.1 (4)
Day of life onset of reported seizure,
median (range)
2.5 (1–16)
Number of Pts treated for clinical
seizures with anti-seizure medications
before admission/EEG
23 (57.5%)
Not treated for clinical seizures 17 (42.5%)
TABLE 2 | Electroencephalographic findings in infants with neonatal abstinence
syndrome observed to manifest with clinical seizures.
Routine EEG and VEEG (n = 40) n (%)
BACKGROUND ACTIVITY
Normal 29 (72.5)
Mildly slow 11 (27.5)
SHARP TRANSIENTS
Fronto- centro-temporal (FCT) 21 (52.5)
Fronto centro temporal occipital (FCTO) 8 (20)
Centro temporal (CT) 7 (17.5)
Centro temporal occipital (CTO) 2 (5)
No transient spikes 2 (5)
SEIZURES
No seizures 37 (92.5)
Seizures present 3 (7.5)
VEEG (n = 18)
Benign neonatal sleep myoclonus (BNSM) 13 (72)
Increased arousal pattern 5 (28)
patients, seizure like clinical activity were described as jerking
or rhythmic movement of extremities, myoclonus during sleep,
apnea, and/or tremors. Based on review of the EEG or VEEG,
only three neonates had epileptic seizure. Findings on EEG are
shown in Table 2. Most of the neonates (72.5%) had normal
background activity and 27.5% had mildly slow activity. Three
neonates (7.5%) with epileptic seizures also had mildly slow
background activity. There were sharp transients in frontal,
central, temporal, and or occipital regions. Additionally, in the 18
(45%) neonates who had continuous video monitoring, detailed
review showed disturbed non-REM sleep with frequent arousal
pattern, jitterymovements, and sleepmyoclonus. BNSMwas seen
in 13/18 (72%) neonates and 5/18 (28%) had increased arousal
pattern. Oxygen saturation monitored by pulse oximetry, blood
glucose, sodium, potassium, and calcium were within normal
limits (Table 3).
TABLE 3 | Oxygen saturations and biochemical parameters on admission.
Parameters Mean and standard
deviation (SD)
Oxygen saturations, % 96.65 (1.57)
Blood glucose, mg/dL 81 (16.69)
Sodium, mmol/L 139 (3.38)
Potassium, mmol/L 4.7 (0.72)
Calcium, mmol/L 9.4 (0.94)
DISCUSSION
We report EEG findings in neonates with NAS, who were
admitted for clinical seizure like activity. The neurological
examination was normal, except for the irritability, tremors,
and increased tone, which are not unusual findings in babies
with NAS.
Herzlinger and co-investigators reported an incidence of
5.9% of documented seizures in neonates with NAS (8). In
our study, of infants with NAS who presented with seizure-
like activity, majority (92.5%) had no electroencephalographic
seizures; only three or 7.5% had seizures consistent with the
EEG pattern. Our findings suggest that seizures if confirmed
by EEG studies occur at a much lower incidence than in
previous reports based on clinical findings. Our findings on EEG
were consistent with disturbed non-REM sleep with frequent
arousal, Jittery movements, or sleep myoclonus (1, 17). Benign
neonatal sleep myoclonus or (BNSM) is a distinctive disorder
characterized by rhythmic myoclonic jerks, which occur when
the child is asleep and stop when the child is awakened. BNSM
may appear on the first day of life and persist for several
weeks to months. BNSM is often mistaken for epilepsy but the
EEGs are always normal. The pathophysiological mechanism
of BNSM is not fully elucidated (18). It may a result of a
benign discharge in the reticular activating system, where the
initiation and synchronization of normal sleep is controlled
(19). Another possibility is that BNSM is related to transient
immaturity or imbalance of the serotoninergic system (20).
Because of the spontaneous resolution with age, BNSM it is
likely related to brain maturation. Previously reported clinical
seizures in NAS could at least in part have been myoclonic
jerks (12). An earlier study showed around 67% of infants with
NAS and had EEG procedure had BNSM (1). In our study
of 18 neonates with VEEG, BNSM was seen in a comparable
incidence (13/18 or 72%). Five or 28% had increased arousal
pattern. In children and adults, the most specific interictal
electrographic signs of the seizure activity are spikes and
sharp waves. The neonatal situation is more complex, since
some sharp transients are commonly seen in their EEG (21).
Further, in healthy neonates, sharp EEG transients usually appear
against a normal background and which do not signify the
presence of encephalopathy nor support the presence of seizures.
The clinical significance of sharp wave transients on neonatal
electroencephalographic (EEG) recordings remains controversial
(22). Rowe et al. stressed that EEG background abnormalities are
a more accurate independent predictor of neurodevelopmental
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outcome rather than sharp wave transients. In our study there
were increased sharp transients in frontal, central, temporal,
and occipital regions, but with normal background activity (23).
EEG background activity was normal in 72.5% of our patients;
none of them had electrical seizures. Eleven or 27.5% had mildly
slow pattern background; the three with electrical seizures were
among those with mildly slow background activity.
Few studies examined sleep in NAS. Opiate-exposed
newborns have shown a significant increase in active sleep
and a reciprocal decrease in quiet sleep than controls (23–26).
O’Brien and Jeffery reported on a reduction of quiet sleep
in infants with NAS compared to their control group (8).
Also, adult and preclinical studies demonstrated that sleep
is altered in opiate withdrawal (27–30). The mechanisms
behind sleep disturbances during NAS remain unclear, but
could be due to changes to the central nervous system
(CNS) during opiate dependency in utero, and due to
hyperactivity of the CNS during withdrawal (23, 25). In
our study, the neonates who had VEEG, 28% did have increased
arousal pattern.
LIMITATIONS
Our study merely focused on infants with NAS admitted
for seizure-like clinical manifestation. VEEG was not
performed in all study subjects. The small number of
infants in our study precluded analysis of any correlation
between the EEG findings and the type of opioids or other
drugs to which the infants were exposed. The impact of
medication used to treat NAS (or seizures) on the EEG was
not analyzed.
CONCLUSION
Clinical manifestation of seizure-like activity correlates poorly
with epileptic seizures in infants with NAS. In infants with a
history of intrauterine drug exposure mainly opioids presenting
with seizure like activity with no other medical conditions,
obtaining a video EEG would be ideal to determine if the
seizure-like manifestation is of epileptic origin, before starting
anti-seizure medication. If available, a VEEG is a preferred
modality to be able to correlate abnormal movements with
electroencephalographic findings.
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